Consolidated net sales for the 2026 June term were 126,595 million yen (YoY +3.2%), operating income was 1,679 million yen (YoY -15.2%), and net income attributable to owners of the parent was 1,112 million yen (YoY -22.2%). The financial summary has been revised. For the 2027 term, earnings guidance is undecided ahead of the merger with DIX. Under Vision2030, the company aims for growth under a new post-merger structure.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2689","jir_company_name":"Orba Healthcare Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/2689-20260828-01.pdf","jir_short_summary":"Consolidated net sales for the 2026 June term were 126,595 million yen (YoY +3.2%), operating income was 1,679 million yen (YoY -15.2%), and net income attributable to owners of the parent was 1,112 million yen (YoY -22.2%). The financial summary has been revised. For the 2027 term, earnings guidance is undecided ahead of the merger with DIX. Under Vision2030, the company aims for growth under a new post-merger structure.","jir_summary":"### Business performance overview\nConsolidated net sales for the 2026 June term reached 126,595 million yen, up 3.2% year on year. On the other hand, operating income declined to 1,679 million yen (down 15.2%), and net income attributable to owners of the parent declined to 1,112 million yen (down 22.2%). Details of sales and profits by segment (medical devices, SPD, and nursing care products) were disclosed. Amid ongoing price pass-through challenges due to rising prices and procurement costs, cost increases also impacted results. The financial summary has been revised, and revised figures have been disclosed. After the merger, maximizing the integration effects to achieve Vision2030 is a key point.\n\n### Future strategy and integration\nWith the merger with DIX effective September 1, 2026, the next corporate group-wide outlook will be disclosed once confirmed. Post-integration, the company plans to establish a position of 'comprehensive \u00d7 specialized' as a medical device distributor by expanding the sales network, creating scale benefits, expanding routes for in-house planned products, optimizing logistics and IT investments, and strengthening human resources development. The dividend policy will prioritize retained earnings, with an expected year-end dividend of 80 yen; however, the post-merger outlook is currently undecided ahead of confirmation.","jir_financial_highlights":"Sales: 126,595 million yen (YoY 3.2% increase)\nOperating income: 1,679 million yen (YoY \u25b315.2%)\nNet income attributable to owners of the parent: 1,112 million yen (YoY \u25b322.2%)\nTotal assets: 46,653 million yen (YoY increase)\nEquity ratio: 28.0% (YoY+1.3pt)","jir_category":"","jir_hashtags":"#OrbaHealthcareHoldingsCo.,Ltd., #FinancialSummary, #ManagementIntegration","jir_key_figures":"Sales: 126,595 million yen\uff08YoY 3.2\uff05 increase\uff09\nOperating income: 1,679 million yen\uff08YoY \u25b315.2\uff05\uff09\nNet income attributable to owners of the parent: 1,112 million yen\uff08YoY \u25b322.2\uff05\uff09","jir_meta_title":"\u3010Orba Healthcare Holdings Co., Ltd.\u30112026 June Term Financial Summary | Integration-Related Trends and Results","jir_meta_description":"Summary of Orba Healthcare Holdings Co., Ltd.'s 2026 June term financial summary. Sales 126,595 million yen, operating income 1,679 million yen, net income 1,112 million yen. Commentary on the DIX merger and Vision2030 strategy.","jir_og_title":"Orba Healthcare Holdings Co., Ltd. Financial Summary and Integration Strategy","jir_og_description":"For the 2026 June term, sales were 126,595 million yen, operating income 1,679 million yen, net income 1,112 million yen. Overview of integration plans and Vision2030 prospects.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58611,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-107879","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n